$NASDAQ:QURE

UNIQURE N.V reports stronger than expected EPS, but revenue misses estimates in Q3 earnings
Gallery

UNIQURE N.V reports stronger than expected EPS, but revenue misses estimates in Q3 earnings

🌧️Trending News UNIQURE N.V ($NASDAQ:QURE) is a leading gene therapy company that focuses on developing treatments for rare and genetic [...]

By GoodWhale|November 7, 2024|Categories: Biotechnology|Tags: $NASDAQ:QURE, Biotechnology, NASDAQ|0 Comments

State Street Corp’s Strategic Transaction Significantly Reduces Holdings in Biotech Firm uniQure NV
Gallery

State Street Corp’s Strategic Transaction Significantly Reduces Holdings in Biotech Firm uniQure NV

🌥️Trending News UNIQURE ($NASDAQ:QURE): uniQure NV is a Dutch biotechnology company that focuses on gene therapies for rare and genetic [...]

By GoodWhale|October 23, 2024|Categories: Biotechnology|Tags: $NASDAQ:QURE, Biotechnology, NASDAQ|0 Comments

UNIQURE N.V Reports Third Quarter Earnings for FY2023
Gallery

UNIQURE N.V Reports Third Quarter Earnings for FY2023

🌥️Earnings Overview UNIQURE N.V ($NASDAQ:QURE) reported its earnings results for the third quarter of FY2023, with the period ending on [...]

By GoodWhale|December 6, 2023|Categories: Biotechnology, Earnings Report|Tags: $NASDAQ:QURE, Biotechnology, NASDAQ|0 Comments

UNIQURE N.V Reports Decreased Revenue of USD 1.4 Million for FY2023 Q3
Gallery

UNIQURE N.V Reports Decreased Revenue of USD 1.4 Million for FY2023 Q3

🌥️Earnings Overview On November 7 2023, UNIQURE N.V ($NASDAQ:QURE) released their FY2023 Q3 earnings results, showing total revenue of USD [...]

By GoodWhale|November 29, 2023|Categories: Biotechnology, Earnings Report, Profitability|Tags: $NASDAQ:QURE, Biotechnology, NASDAQ|0 Comments

Uniqure N.v Intrinsic Stock Value – uniQure Stock Falls Below 200-Day Moving Average of $11.00
Gallery

Uniqure N.v Intrinsic Stock Value – uniQure Stock Falls Below 200-Day Moving Average of $11.00

🌥️Trending News UNIQURE ($NASDAQ:QURE): uniQure N.V is a biopharmaceutical company based in Amsterdam, Netherlands. The company is dedicated to developing [...]

By GoodWhale|November 23, 2023|Categories: Biotechnology, Intrinsic Value|Tags: $NASDAQ:QURE, Biotechnology, NASDAQ|0 Comments

UNIQURE N.V Reports Quadrupling of Revenue for Second Quarter of FY2023
Gallery

UNIQURE N.V Reports Quadrupling of Revenue for Second Quarter of FY2023

🌥️Earnings Overview For the second quarter of FY2023, UNIQURE N.V ($NASDAQ:QURE) reported a total revenue of USD 2.4 million, a [...]

By GoodWhale|August 9, 2023|Categories: Biotechnology, Earnings Report, Profitability|Tags: $NASDAQ:QURE, Biotechnology, NASDAQ|0 Comments

Uniqure N.v Intrinsic Stock Value – Analysts Increase Earnings Forecasts for uniQure N.V., Shareholders Rejoice!
Gallery

Uniqure N.v Intrinsic Stock Value – Analysts Increase Earnings Forecasts for uniQure N.V., Shareholders Rejoice!

☀️Trending News UNIQURE ($NASDAQ:QURE): UniQure N.V. is a leader in the gene therapy field, researching novel treatments for serious, life-threatening [...]

By GoodWhale|June 29, 2023|Categories: Biotechnology|Tags: $NASDAQ:QURE, Biotechnology, NASDAQ|0 Comments

Market Underestimating Impact of FDA and EU EMA Approvals for uniQure N.V.
Gallery

Market Underestimating Impact of FDA and EU EMA Approvals for uniQure N.V.

Trending News 🌥️ UNIQURE ($NASDAQ:QURE): The market is currently underestimating the impact of the recent FDA and EU EMA approvals [...]

By GoodWhale|May 23, 2023|Categories: Biotechnology|Tags: $NASDAQ:QURE, Biotechnology, NASDAQ|0 Comments

Uniqure N.v Stock Intrinsic Value – uniQure Profits Increase After Selling Portion of CSL Royalty Interest
Gallery

Uniqure N.v Stock Intrinsic Value – uniQure Profits Increase After Selling Portion of CSL Royalty Interest

Trending News ☀️ UNIQURE N.V ($NASDAQ:QURE) is a biotechnology company focused on developing gene therapy treatments for patients suffering from [...]